    Shelley Fussey | Peregrine Pharmaceuticals , Inc. | ZoomInfo.com









Bio - Shelley P. M. Fussey, Ph.D.






























HomeAboutOverviewManagement TeamBoard of DirectorsMedical and Scientific AdvisorsCareersTotal Rewards ProgramPhilip Thorpe: PS-Targeting Antibody InventorPipelineOverviewBavituximab OncologyCotara OncologyPGN650 Tumor ImagingBavituximab AntiviralClinical TrialsOverviewUnderstanding Clinical TrialsBavituximab TrialsPublicationsPublicationsPosters and PresentationsBiomanufacturingInvestorsReverse Stock Split FAQ'sUpcoming EventsNews ReleasesSEC FilingsCorporate GovernanceStock Quote & ChartAnalyst CoverageInvestor FAQsE-mail Alerts 











Peregrine Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing therapeutics to stimulate the body's immune system to fight cancer. 




Contact Us  |  Avid  |  Sitemap 





 



 










 



 



 








Home > About > Management Team > Bio - Shelley P. M. Fussey, Ph.D.















OverviewManagement TeamBoard of DirectorsMedical and Scientific AdvisorsCareersPhilip Thorpe: PS-Targeting Antibody Inventor 













Shelley P. M. Fussey, Ph.D.
Vice President, Intellectual Property
Shelley P.M. Fussey, Ph.D. has served as our Vice President, Intellectual Property since February 2005. Dr. Fussey plays a key role in our U.S. and international patenting, patent analysis and patent defense. Dr. Fussey's expertise includes patent strategy for technologies developed both in-house and in-licensed from universities. She has broad experience in intellectual property consulting for areas including cancer treatment, immunology, and antiviral technology, as well as other areas central to pharmaceutical and biotechnology drug development. Prior to joining Peregrine, Dr. Fussey worked for the law firms of Williams, Morgan & Amerson and Arnold, White and Durkee. She holds a Ph.D. in Biochemistry and a B.Sc. in Biochemistry with First Class Honours (Summa Cum Laude) from the University of Newcastle upon Tyne, U.K.



 


 






Copyright © 2003-2017 Peregrine Pharmaceuticals Inc., All Rights Reserved
 
DisclaimerSafe Harbor 



 














Insider Trading - Fussey Shelley Pm - Form 4 SEC Filings












Home |
Archives |
Products |
About |
Contact |
FAQ |



New User?
Sign Up | 
Sign In









Form 4 Filings


Insider Buys


Significant Buys


Penny StocksInsider Buying


Insider Sales




Insider Buy Sell Ratios


Stock Options


Insider TradingStock Screener


Insider TradingGraph View


Insider Watch





Sec Filings Insider Trading - Fussey Shelley Pm





Select Time period: 
1 Month
2 Months
3 Months
6 Months
1 Year
2 Years
3 Years
4 Years
All Data
 

     



google

   



yahoo!



Send this page to:  

Blog
  



Digg

  



Reddit

  



Facebook

  



Stumble

  



del.icio.us








Enter Stock Ticker Symbol or Cik:




Cik Lookup...






Search By Company or Insider Name:







"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch ==>>

What is insider trading>>



Email a friend >>...







Historical filings delayed by 6 months. New user?
Sign Up for real time data.
Existing user?
Sign In

Stock options: Exercise, Award, Grant, Conversion



TransactionDate
ReportedDate
ExercisableExpiration
Company
Symnbol
InsiderRelationship
SharesTraded
ConversionPrice
SharesOwned
Filing




2016-10-31Other
2016-11-017:58 pm
N/AN/A
Peregrine Pharmaceuticals Inc
PPHM
Fussey Shelley PmV.P., Intellectual Property
25,433
$0.2864
135,908(Direct)
View


2016-06-02Option Award
2016-06-037:51 pm
2016-09-022026-06-02
Peregrine Pharmaceuticals Inc
PPHM
Fussey Shelley PmV.P., Intellectual Property
150,000
$0.5001
893,000(Direct)
View


2016-04-29Other
2016-05-028:18 pm
N/AN/A
Peregrine Pharmaceuticals Inc
PPHM
Fussey Shelley PmV.P., Intellectual Property
10,683
$0.301
110,475(Direct)
View


2015-10-30Other
2015-11-024:16 pm
N/AN/A
Peregrine Pharmaceuticals Inc
PPHM
Fussey Shelley PmV.P., Intellectual Property
8,448
$0.95
99,792(Direct)
View


2015-05-11Option Award
2015-05-128:02 pm
2015-08-112025-05-11
Peregrine Pharmaceuticals Inc
PPHM
Fussey Shelley PmV.P., Intellectual Property
75,000
$1.31
743,000(Direct)
View


2015-04-30Other
2015-05-0112:56 pm
N/AN/A
Peregrine Pharmaceuticals Inc
PPHM
Fussey Shelley PmV.P., Intellectual Property
7,179
$1.11
91,344(Direct)
View









    © 2005-2017 SecForm4.Com All rights reserved.
    Archives:
    2017 2016 2015 2014 2013 2012 ... 
    Fri, 28 Jul 2017 16:39:19 -0500
  

    SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
    SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC).
Terms of Use |
    Privacy Statement |
  










Shelley PM  Fussey - CEO, founder, businessman - profile

















directorpedia.net - List of CEOs, founders, board members and company directors











Shelley PM  Fussey
Check out list of companies and businesses related to Shelley PM  Fussey. Find out Shelley PM  Fussey address and contact details. View other people related to Shelley PM  Fussey - coworkers, colleagues, companions, etc.
Address:   

14282 FRANKLIN AVENUE  TUSTIN, 92780 CA




Companies related to Shelley PM  Fussey
CIKCompany NamePositionCompany Address0000704562PEREGRINE PHARMACEUTICALS INCV.P., Intellectual Property 14282 FRANKLIN AVE  TUSTIN 92780




Shelley PM  Fussey on the Web
Persons related to Shelley PM  Fussey - PEREGRINE PHARMACEUTICALS INCNamePositionCityKA  AJIT-SIMHTUSTINKENNETH BRYAN  DARTGRAND CAYMANEastern Capital LTDGRAND CAYMANShelley PM  FusseyV.P., Intellectual Property TUSTINShelley PM  FusseyVP, Intellectual Property TUSTIN,Shelley PM  FusseyV.P., Intellectual Property TUSTINShelley PM  FusseyV.P., Intellectual Property TUSTINShelley PM  FusseyV.P., Intellectual Property TUSTIN,Shelley PM  FusseyV.P., Intellectual Property TUSTINCARLTON M  JOHNSONDirector TUSTIN,CARLTON M  JOHNSONDirector TUSTINCARLTON M  JOHNSONDirector TUSTINCARLTON M  JOHNSONDirector TUSTIN,CARLTON M  JOHNSONDirector TUSTINF David  KingTUSTIN,F David  KingV.P. Business Development TUSTINF David  KingV.P., Business Development TUSTIN,F David  KingV.P., Business Development TUSTIN,STEVEN W  KINGPresident & CEO TUSTINSTEVEN W  KINGPresident & CEO TUSTINSTEVEN W  KINGPresident & CEO TUSTIN,STEVEN W  KINGPresident & CEO TUSTIN,STEVEN W  KINGPresident & CEO TUSTINSTEVEN W  KINGPresident & CEO TUSTIN,STEVEN W  KINGPresident & CEO TUSTINSTEVEN W  KINGPresident & CEO TUSTINEDWARD J  LEGERE IITUSTINPAUL J  LYTLEChief Financial Officer TUSTINPAUL J  LYTLEChief Financial Officer TUSTIN,PAUL J  LYTLEChief Financial Officer TUSTIN,PAUL J  LYTLEChief Financial Officer TUSTINPAUL J  LYTLEChief Financial Officer TUSTINPAUL J  LYTLEChief Financial Officer TUSTINPAUL J  LYTLEChief Financial Officer TUSTINPAUL J  LYTLEChief Financial Officer TUSTINJeffrey L.  MastenTUSTINJeffrey L.  MastenV.P. Quality TUSTINJeffrey L.  MastenV.P. Quality TUSTINJeffrey L.  MastenV.P. Quality TUSTINDAVID  POHLDirector DAVID  POHLDirector TUSTINDAVID  POHLDirector TUSTINDAVID  POHLTUSTIN,DAVID  POHLDirector TUSTINDAVID  POHLDirector TUSTIN,DAVID  POHLTUSTINPortfolio Services Ltd.GRAND CAYMANJoseph  ShanVP, Clinical and Reg Affairs TUSTIN,Joseph  ShanVP Clinical/Regulatory Affairs TUSTIN,Joseph  ShanVP, Clinical and Reg Affairs TUSTINJoseph  ShanVP, Clinical/Regulatory Affair TUSTINJoseph  ShanV.P. Clinical & Reg. Affairs TUSTINJoseph  ShanV.P., Clinical & Reg. Affairs TUSTINJoseph  ShanV.P., Clinical and Reg Affairs TUSTINERIC S  SWARTZDirector TUSTIN,ERIC S  SWARTZDirector TUSTINERIC S  SWARTZDirector TUSTINERIC S  SWARTZDirector TUSTIN, CAERIC S  SWARTZDirector TUSTINERIC S  SWARTZDirector TUSTINERIC S  SWARTZDirector TUSTINERIC S  SWARTZDirector TUSTINERIC S  SWARTZDirector TUSTIN,ERIC S  SWARTZDirector TUSTIN,ERIC S  SWARTZDirector TUSTINCLIVE R  TAYLORDirector TUSTINThomas A  WaltzTUSTIN,Thomas A  WaltzDirector TUSTINThomas A  WaltzDirector TUSTINThomas A  WaltzDirector TUSTIN,Mark R  ZiebellVP and General Counsel TUSTIN












 








Shelley P.m. Fussey, Ph.d. Williams, Morgan & Amerson, P.C. Patents









 


  FREE patent keyword monitoring and additional FREE benefits.  REGISTER now for FREE 
 




    



















    SEARCH FreshPatents:   
  |  Free: Monitor Keywords



Browse: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 1 | 3 | 

Shelley P.m. Fussey, Ph.d. Williams, Morgan & Amerson, P.C. patentsThe following is a sampling of recent Shelley P.m. Fussey, Ph.d. Williams, Morgan & Amerson, P.C. patent applications (USPTO Patent Application #, Patent Title) sorted by month.December 2005 - Shelley P.m. Fussey, Ph.d. Williams, Morgan & Amerson, P.C. patents
		20050265977 - Xenotransplant for cns therapy June 2005 - Shelley P.m. Fussey, Ph.d. Williams, Morgan & Amerson, P.C. patents
		20050130203 - Novel gabab receptor dna sequences20050123537 - Antibody conjugate methods for selectively inhibiting vegf ###This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Shelley P.m. Fussey, Ph.d. Williams, Morgan & Amerson, P.C. in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Shelley P.m. Fussey, Ph.d. Williams, Morgan & Amerson, P.C. with additional patents listed. Browse our Agent directory for other possible listings. Advertise on FreshPatents.com - Rates & Info###Design/code © 2014 FreshContext LLC/Freshpatents.com.Patent data source: patents published by the United States Patent and Trademark Office (USPTO)Information published here is for research/educational purposes only (and in conjunction with our Keyword Monitor) and is not meant to be used in place of the full USPTO patent document/images or a comprehensive patent archive search. Complete official applications are on file at the USPTO and may contain additional data/images. FreshPatents.com is not affiliated with or endorsed by the USPTO or firms/individuals or products/designs/ideas related to listed patents and there may be applicable trademarks or servicemarks within the documents.FreshPatents.com Support - Terms & Conditions
















 - NASDAQ.com




























































Hot Topics:
ETFs |
Smart Portfolio |
Currencies |
Online Broker Center















Search






















Home > 
    Quotes > 
    Ownership & Insider Trades > 
    Individual Insiders












Click on the column header to resort ascending (▲) or descending (▼).



Individual Insider Trades



Company


Relation


Last Date ▼


Type


Tran


OwnerType


Shares Traded


Last Price


Shares Held
















Highest Rated Articles of Last Week



Shareholders Approve Major Structural Change to Top Performing...
Yatra Attains Leadership Position in Corporate Travel With the...
Mitel To Acquire ShoreTel - Quick Facts
Miller Heiman Group Selects CallidusCloud Datahug for Pipeline...
Tractor Supply Company Reports Second Quarter Results





View All Highest Rated































Most Rated Stocks of Last Week
Rated stocks for NASDAQ, NYSE and AMEX

Symbol  /  Ratings Consensus

AAPL

86% bullish
                    of
                    2913
                    ratings
Rate It


FB

76% bullish
                    of
                    1328
                    ratings
Rate It


TSLA

78% bullish
                    of
                    588
                    ratings
Rate It


MSFT

84% bullish
                    of
                    649
                    ratings
Rate It


GOOG

91% bullish
                    of
                    128
                    ratings
Rate It


JPM

70% bullish
                    of
                    88
                    ratings
Rate It


GM

68% bullish
                    of
                    80
                    ratings
Rate It


BAC

75% bullish
                    of
                    475
                    ratings
Rate It


NFLX

68% bullish
                    of
                    325
                    ratings
Rate It


INTC

83% bullish
                    of
                    266
                    ratings
Rate It


More Most Rated Stocks



























CLOSEX

Edit Favorites

Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.






Update

Clear List







CLOSEX
Customize your NASDAQ.com experience
Background Color Selector

Select the background color of your choice:





 Black
							





 Slate Gray
							






 Light Gray
							





 Gray Blue
							






Quote Search

Select a default target page for your quote search:



						 Real-Time

						 After Hours

						 Pre-Market
 News
					


						 Flash Quote

						 Summary Quote

						 Interactive Charts

						 Default Setting




					Please note that once you make your selection, it will apply to all future visits to NASDAQ.com.
					If, at any time, you are interested in reverting to our default settings, please select Default Setting above.
					
					If you have any questions or encounter any issues in changing your default settings, please email isfeedback@nasdaq.com.
				





CLOSEX
Please confirm your selection:

					You have selected to change your default setting for the Quote Search. This will now be your default target page;
					unless you change your configuration again, or you delete your
					cookies. Are you sure you want to change your settings?


YES
NO













CLOSEX


Please disable your ad blocker (or update your settings to ensure that javascript and cookies are enabled), so that we can continue to provide you with the first-rate market news and data you've come to expect from us.





CLOSEX



































Stock Screener - Yahoo FinanceHomeMailFlickrTumblrNewsSportsFinanceCelebrityAnswersGroupsMobileMoreYahooSearchSearch0U.S. Markets closedS&P 5002,472.10-3.32 (-0.13%)Dow 3021,830.31+33.76 (+0.15%)Insider TransactionsDefault CriteriaInsider & Restricted Shareholder Transactions1-3 of 3 resultsResults were generated a few mins ago. Pricing data is updated frequently. Currency in USDSymbolDateSharesProceedsTransaction DetailsPPHM2016-10-3025,433$7,376.00Acquisition (Non Open Market) at $0.29 per share.PPHM2016-04-2810,683$3,000.00Acquisition (Non Open Market) at $0.30 - $0.30 per share.PPHM2015-10-298,448$8,000.00Acquisition (Non Open Market) at $0.95 - $0.95 per share.Trump names John Kelly new chief of staff; Reince Priebus outCNBCAlaska Has Never Looked More BeautifulYahoo SearchSponsoredThe 'two pizza rule' is a secret to productive meetings that helped Amazon CEO Jeff Bezos become one of the world's richest menBusiness InsiderYahoo Small BusinessData DisclaimerHelpSuggestionsPrivacyAbout Our AdsTerms (Updated)







Shelley P M Fussey, Patent Agent, Biography, Houston Texas, 39458 - Patent Buddy







































Patent Buddy

Sign In     |     Join Today





















Free



Premium



Professional



Enterprise








Patent Searching

 

 

 



Technology Searching






Owner and Inventor Searching






Patent Analytics






Owner Analytics






Attorney Analytics






Inventor Analytics






Technology Analytics






Mobile Searching






Tagging






Advanced Patent Analytics

 

 

 



Advanced Owner Analytics






Mobile Portfolio/Analytics






Detailed Attorney Information






Prosecution analytics






Pre-publication Data






Monthly PAIR Information and Watches







						Number of patents in all portfolios
						
100 (maximum)
1000 (maximum)
2000 (maximum)
Unlimited


Follows
							in all categories (Watch)

						10 (maximum)
						
50 (maximum)
500 (maximum)
Unlimited


Maximum number of portfolios
5 (maximum)
10 (maximum)
100 (maximum)
Unlimited


Maximum number of comparisons
1 (maximum)
 
5 (maximum)
 
20 (maximum)
 
Unlimited










FREE

 

$9.95/mo

 

$39.95/mo

 

$99.95/mo



 
 
 
 
 
 



PAIR
									Watch Weekly Update
$2.75/mo/patent
$2.65/mo/patent


PAIR
									Watch Daily Update
$5.75/mo/patent
$5.55/mo/patent


Upgrade Now

 
Upgrade Now

 
Upgrade Now

 
Upgrade Now










Welcome to PatentBuddy 2.0!  Please enjoy the 30+ day free trial of our  level membership.  If you wish to continue with a paid membership, please select a membership plan before the year end expiration date.  Otherwise, all portfolios and followings will be reset to our free membership plan after the expiration date.






Free



Premium



Professional



Enterprise








Patent Searching

 

 

 



Technology Searching






Owner and Inventor Searching






Patent Analytics






Owner Analytics






Attorney Analytics






Inventor Analytics






Technology Analytics






Mobile Searching






Tagging






Advanced Patent Analytics

 

 

 



Advanced Owner Analytics






Mobile Portfolio/Analytics






Detailed Attorney Information






Prosecution analytics






Pre-publication Data






Monthly PAIR Information and Watches







						Number of patents in all portfolios
						
100 (maximum)
1000 (maximum)
2000 (maximum)
Unlimited


Follows
							in all categories (Watch)

						10 (maximum)
						
50 (maximum)
500 (maximum)
Unlimited


Maximum number of portfolios
5 (maximum)
10 (maximum)
100 (maximum)
Unlimited


Maximum number of comparisons
1 (maximum)
 
5 (maximum)
 
20 (maximum)
 
Unlimited










FREE

 

$9.95/mo

 

$39.95/mo

 

$99.95/mo



 
 
 
 
 
 



PAIR
									Watch Weekly Update
$2.75/mo/patent
$2.65/mo/patent


PAIR
									Watch Daily Update
$5.75/mo/patent
$5.55/mo/patent


Upgrade Now

 
Upgrade Now

 
Upgrade Now

 
Upgrade Now









Please Confirm Your Upgraded Plan Purchase By Selecting Upgrade Button

  Yearly (Get 12 months for the price of 11!)  MonthlyUPGRADECANCEL












Free



Premium



Professional



Enterprise








Patent Searching

 

 

 



Technology Searching






Owner and Inventor Searching






Patent Analytics






Owner Analytics






Attorney Analytics






Inventor Analytics






Technology Analytics






Mobile Searching






Tagging






Advanced Patent Analytics

 

 

 



Advanced Owner Analytics






Mobile Portfolio/Analytics






Detailed Attorney Information






Prosecution analytics






Pre-publication Data






Monthly PAIR Information and Watches







						Number of patents in all portfolios
						
100 (maximum)
1000 (maximum)
2000 (maximum)
Unlimited


Follows
							in all categories (Watch)

						10 (maximum)
						
50 (maximum)
500 (maximum)
Unlimited


Maximum number of portfolios
5 (maximum)
10 (maximum)
100 (maximum)
Unlimited


Maximum number of comparisons
1 (maximum)
 
5 (maximum)
 
20 (maximum)
 
Unlimited










FREE

 

$9.95/mo

 

$39.95/mo

 

$99.95/mo



 
 
 
 
 
 



PAIR
									Watch Weekly Update
$2.75/mo/patent
$2.65/mo/patent


PAIR
									Watch Daily Update
$5.75/mo/patent
$5.55/mo/patent


Upgrade Now

 
Upgrade Now

 
Upgrade Now

 
Upgrade Now










Please Confirm Your Upgraded Plan Purchase By Selecting Upgrade Button

  Yearly (Get 12 months for the price of 11!)  MonthlyUPGRADECANCEL




















Shelley P M Fussey
U.S. Patent Agent






Stats



Peregrine Pharmaceuticals Inc

 organization

				22 years in practice

This is official USPTO record data
 

Professional Information

Organization
Peregrine Pharmaceuticals Inc
				
						
				
	Title
							

				Patent Agent
Registration #

				39458
				
Experience




Years In Practice

				22
Registered On

										May 08, 1995 (As Agent)
				
				
				

 


 View all USPTO data 

Login to view full profile information, such as:
- Contact Information
- Job Information
- Current and Previous Co-Workers












Note
The template below is formatted to ensure compatibility with our system.
							Provide tags with | separated like (tags1|tags2).

Mandatory Fields * - 'MatterType','AppType','Country','Title','SerialNo'.

Acceptable Date Format - 'MM/DD/YYYY'.

Acceptable Filing/App Types - 

Continuation/Divisional
Original
Paris Convention
PCT National
With Priority
EP Validation
Provisional Conversion
Reissue
Provisional
Foreign Extension

Acceptable Status - 

Pending
Abandoned
Unfiled
Expired
Granted

Acceptable Matter Types - 

Patent
Utility Model
Supplemental Protection Certificate
Design
Inventor Certificate
Plant
Statutory Invention Reg



Advertisement


  




Advertisement

Email Yourself the App Links



Advertisement






Advertisement





Advertisement





Recipient Email Address 


Send Email





Recipient Email Address 

Send Email



Comment 







Recipient Email Address 

Send Email






Success
E-mail has been sent successfully.




Failure
Some error occured while sending email. Please check e-mail and try again!








View Full Site

	Copyright 2017 PatentBuddy.
Help | Advertise | Contact | Terms | Privacy | About Usfalse






Fussey Shelley PM Top Holdings  

































WhaleWisdom









Search All
Search 13F Filers Only
Search SEC Filer
Search Stocks Only
Search Mgmt Inv. Cos Only
ETFs Only
Search Active




















                      Fussey Shelley PM
                    

•   TUSTIN, CA
                      
How do I update this listing?




                                             Fussey Shelley PM is based out of Tustin.    WhaleWisdom has at least 9 insider transactions (Form 3,4,5) in our database for Fussey Shelley PM. 
                                           














Summary
13D/G
Insider (Form 4)



   Create Email Alert
 




×
Email Notification.







                   ***Log In or
                   Sign-up
                   to see more advanced email alert options such as selecting any type of
                   SEC form, multiple filers or classes of filers, and much more.***
                 

                    ...or to simply have an email sent to you whenever we receive a new
                           13F filing from Fussey Shelley PM, enter your
                    email address below and choose 'Submit'.
                

Your email:








Cancel














Contact Info




fussey shelley pm


14282 FRANKLIN AVENUE

TUSTIN
CA
                                                        
                                                    92780


                                                      Business Phone:
                                                      7145086000
SEC SIC CODE:2835-IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES







Recent SEC Filings




4 filed on 11/01/2016
4 filed on 06/03/2016
4 filed on 05/02/2016
4 filed on 11/02/2015
4 filed on 05/12/2015
4 filed on 05/01/2015
4 filed on 11/04/2014
4 filed on 05/08/2014
4 filed on 05/01/2014
4 filed on 11/01/2013
















Schedule 13D and 13G events since 03/31/2017

Subscription required



 
Form 4 - Non-derivative Insider Transactions Since 03/31/2017
Loading...








Elevate your investments
Try it for free



























Shelley Pm Fussey - Peregrine Insider Transactions | TipRanks   





Go ProLogin / Sign Up Follow✓Get Real Time TransactionsInsider DetailsShelley Pm FusseyPeregrine (PPHM)V.P., Intellectual Property Not RankedShelley Pm Fussey's PerformanceShelley Pm Fussey has not reported any informative transactions and therefore cannot be ranked.How are Insiders Ranked? Insider Holdings 100.0% Peregrine (PPHM)$83KSee the Top Stocks by Insiders > Insider RolesPeregrine (PPHM): V.P., Intellectual PropertySee the Top 25 Corporate Insiders > Shelley Pm Fussey's Trading Historybased on Form 4 Follow✓Get Real Time TransactionsCompany NameInsider PositionHolding ValueLast TransactionLast Transaction  AmountLast Transaction DatePPHMPeregrineV.P., Intellectual Property$82,605Uninformative Buy$7,121.24Nov 01, 2016Shelley Pm Fussey has not reported any informative transactions for PPHM, therefore, performance cannot be measured. Track Record DateTransactionAmountNo. of SharesPrice per ShareProfitForm 4 Nov 01, 2016 Uninformative Buy $7K 25,433 $2.233 N/A  May 02, 2016 Uninformative Buy $3K 10,683 $2.59 N/A  Nov 02, 2015 Uninformative Buy $8K 8,448 $8.19 N/A Show MoreSee All Insider Trading from Today >You May Also LikeMeet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.Related LinksHow can I benefit from Insider Trading? >See the Top 25 Corporate Insiders >Go to Hot Stocks by Insiders >Find which stocks Insiders traded today >Become a TipRanks MemberGet the best Investing Tips & Hacks straight to your emailFree MembershipSubmitInsider Trading Daily NewsletterProfessional day-trading strategy based on predictive insider transactionsAnnual Return: +85.42%Learn More >Powered by
























